G

The first “male IUD” could soon revolutionize contraception

What if contraceptive responsibility became genuinely shared? In Lille, a dedicated team of researchers is currently working on the “STEOM,” touted as the world’s first male IUD. Non-hormonal, reversible, and easily inserted in a matter of minutes, this device could fundamentally alter how heterosexual couples view contraception in the years ahead.

How does a male IUD actually work?

The “STEOM” operates on a mechanical principle akin to that of female IUDs: it prevents sperm passage without altering hormones or permanently affecting fertility. The device is implanted during a simple procedure performed under local anesthesia, lasting around fifteen minutes and requiring only a minor incision in the scrotum. According to the doctors behind the project, there is no need for stitches or extensive dressings.

Designed to remain in place for three years, the device can be safely removed or replaced by a trained professional. The clear objective is to offer a male contraceptive method that is reversible, straightforward, and non-hormonal.

A solution born from the need for more options

The initiative stems from andrologist Julie Prasivoravong, who aimed to broaden the contraceptive choices available to men. Currently, male options remain limited to condoms, so-called “natural” methods, and vasectomy—often viewed as a permanent solution despite its occasionally reversible nature.

The “STEOM” has been conceived as a more flexible alternative, backed by the Lille University Hospital in collaboration with the University of Liège and several researchers specializing in medical technologies. The idea is gaining traction, particularly as it addresses an increasingly pressing question in contraceptive discourse: why does the burden typically fall predominantly on women?

Clinical trials on the horizon

Preclinical trials began in May 2026 at the University of Liège. Should the results prove satisfactory, clinical trials are expected to follow, involving around one hundred volunteers in France and Belgium.

However, before any potential commercialization, the device must navigate a series of stringent regulatory requirements. The “STEOM” falls under a heavily regulated category of medical devices, with exceptionally high safety standards. Consequently, it may take seven to ten years before it becomes available on the market.

Contraception still largely shouldered by women

The introduction of the “STEOM” reignites a familiar debate about sharing contraceptive responsibility. Currently, the majority of contraceptive methods used still rely on women’s bodies. Birth control pills, hormonal IUDs, implants, and patches often impose significant physical, psychological, or hormonal burdens.

Conversely, an increasing number of men are opting for vasectomies. In France, the number of these procedures has risen sharply in recent years, indicating that a segment of the male population is keen on taking a more active role in contraception. Therefore, the “STEOM” could mark an important milestone in this evolving landscape.

A detail that sparks discussion

On social media, one recurring theme in discussions is the striking observation that a male contraceptive option has been developed specifically to be “hormone-free,” while women have dealt with hormonal contraceptives for decades, often accompanied by significant side effects. Weight gain, migraines, reduced libido, fatigue, and emotional fluctuations are just some of the challenges many women report regarding various hormonal methods.

This contrast highlights a historical disparity in how medicine has approached contraceptive solutions for different genders. Nevertheless, some users emphasize that expanding contraceptive options for men is a positive advancement—especially if it leads to a more equitable distribution of contraceptive responsibility within couples.

In summary, with the “STEOM,” male contraception enters a new phase of consideration. Beyond the medical innovation, this project invites broader conversations around shared responsibilities, the understanding of bodily autonomy, and the diversity of contraceptive choices.